deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT01157429

D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents

D-cycloserine Adjunctive Treatment for PTSD in Adolescents

Sponsor: National Alliance for Research on Schizophrenia and Depression

Conditions PTSD Posttraumatic Stress Disorder
Interventions CBT D-cycloserine Placebo pill
Updated 9 times since 2017 Last updated: Apr 25, 2017 Started: Jun 30, 2010 Primary completion: Jun 30, 2012 Completion: Jun 30, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01157429, this PHASE2 trial focuses on PTSD and Posttraumatic Stress Disorder and remains completed. Sponsored by National Alliance for Research on Schizophrenia and Depression, it has been updated 9 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Jul 2017 · 5 months · monthly snapshotUnknown Status~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE2

▶ Show 4 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  2. Jul 2017 — Jun 2018 [monthly]

    Completed PHASE2

    Status: Unknown Status → Completed

  3. Feb 2017 — Jul 2017 [monthly]

    Unknown Status PHASE2

  4. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE2

    First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Alliance for Research on Schizophrenia and Depression
  • Tulane University School of Medicine
Data source: Tulane University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations